The Wren Laboratories NETest and its recent expansion into the Chinese Market was the subject of a feature article by Forest Ray in The article characterized our decision to focus on mRNA as the basis for our diagnostic platform and also discusses a little bit about diagnostics in our pipeline, specifically our PROSTest.

Read the article: